Bloomberg: Trump Urged by Democratic Senators to Keep Biden’s Drug Price Cuts

A group of lawmakers are urging President Donald Trump to reject pharmaceutical companies' efforts to pause the Biden administration's drug-price cuts.

Trump should use his deal-making skills to "flat out reject any request to end negotiations from giant pharmaceutical makers that have spent decades putting profits over patients," Democratic Senators Elizabeth Warren of Massachusetts and Ron Wyden of Oregon and Independent Bernie Sanders of Vermont wrote in a letter to the president seen by Bloomberg.

"There is no legal basis for any pause, and allowing giant pharmaceutical companies to pressure you into one would dramatically increase costs for over 60 million Medicare beneficiaries and betray your own campaign promises," the lawmakers said.

The letter follows Bloomberg’s reporting last week that drugmakers including Eli Lilly & Co. are planning to ask the Trump administration to pause price negotiations. Under Biden’s Inflation Reduction Act, the US government is allowed to pay lower prices for older medications in the Medicare health program for seniors.

...

Read the full article here.

• Print
• Email
• Tweet